-The Indian Express Government privileges the private over the public, preferring trade to health In a dramatic development, US industry groups recently claimed the Indian government offered them a “private” assurance that compulsory licences will not be issued, save in emergencies and for non-commercial purposes. Needless to state, such an assurance flies in the face of the Patents Act and the public health safeguards enshrined in it. Illustratively, Section 84 mandates that...

-The Hindu Clark made a significant pitch for all countries that had not made domestic abuse and marital rape criminal offences to do so at the earliest. Just days after Minister of Women and Child welfare Maneka Gandhi submitted in parliament that the government wouldn’t criminalise “marital rape”, a top UN official said that the issue is one of consent, not culture, suggesting that India would be in contravention of the Sustainable...

-The Hindu Business Line The wool of this north Karnataka breed has helped the herder community handcraft a crorepati business These sheep, strikingly black, have a rich coat of coarse wool that has long provided the army and police force with a steady supply of warm blankets. Called Deccani, the lambs are sheared twice a year, each of them yielding a little over one kg of raw wool, which is ideal for...

-AP New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations. The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine. If Pfizer is...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...